Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis

Background. Thyroid disorders commonly affect the cardiovascular system. Thyrotoxicosis leading to pulmonary hypertension has been increasingly reported during recent years. Thyroid dysfunction affects the lipid metabolism, and thyrotoxicosis can be associated with low lipid levels. Thyrotoxicosis p...

Full description

Bibliographic Details
Main Authors: Narangoda Liyanage Ajantha Shyamali, Chandrike Ponnamperuma
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2020/8884061
id doaj-f7df0cae840b49588dcbe59c5c0c21fb
record_format Article
spelling doaj-f7df0cae840b49588dcbe59c5c0c21fb2020-11-30T09:11:25ZengHindawi LimitedCase Reports in Endocrinology2090-65012090-651X2020-01-01202010.1155/2020/88840618884061Pulmonary Hypertension and Hypocholesterolemia Secondary to ThyrotoxicosisNarangoda Liyanage Ajantha Shyamali0Chandrike Ponnamperuma1University of Sri Jayewardenepura, Gangodawila, Nugegoda, Sri LankaNational Hospital of Sri Lanka, Colombo 10, Sri LankaBackground. Thyroid disorders commonly affect the cardiovascular system. Thyrotoxicosis leading to pulmonary hypertension has been increasingly reported during recent years. Thyroid dysfunction affects the lipid metabolism, and thyrotoxicosis can be associated with low lipid levels. Thyrotoxicosis presenting with right ventricular dysfunction is rare, and only few cases had been reported. Case Presentation. A 53-year-old woman presented with progressive shortness of breath and swelling of body for four months. Examination showed generalized oedema and a systolic murmur over the left sternal border. Transthoracic echocardiography confirmed pulmonary hypertension with tricuspid regurgitation. Investigations revealed thyrotoxicosis and very low cholesterol levels. Diagnosis of Graves’ disease was confirmed with detection of thyrotropin receptor antibodies. Pulmonary pressure was normalized six months after antithyroid therapy. Conclusion. Thyrotoxicosis is a recognized cause of reversible pulmonary hypertension and acquired hypocholesterolemia. However, most clinicians are not aware of these associations. This case illustrates the importance of assessing thyroid function in patients presenting with pulmonary hypertension.http://dx.doi.org/10.1155/2020/8884061
collection DOAJ
language English
format Article
sources DOAJ
author Narangoda Liyanage Ajantha Shyamali
Chandrike Ponnamperuma
spellingShingle Narangoda Liyanage Ajantha Shyamali
Chandrike Ponnamperuma
Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis
Case Reports in Endocrinology
author_facet Narangoda Liyanage Ajantha Shyamali
Chandrike Ponnamperuma
author_sort Narangoda Liyanage Ajantha Shyamali
title Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis
title_short Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis
title_full Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis
title_fullStr Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis
title_full_unstemmed Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis
title_sort pulmonary hypertension and hypocholesterolemia secondary to thyrotoxicosis
publisher Hindawi Limited
series Case Reports in Endocrinology
issn 2090-6501
2090-651X
publishDate 2020-01-01
description Background. Thyroid disorders commonly affect the cardiovascular system. Thyrotoxicosis leading to pulmonary hypertension has been increasingly reported during recent years. Thyroid dysfunction affects the lipid metabolism, and thyrotoxicosis can be associated with low lipid levels. Thyrotoxicosis presenting with right ventricular dysfunction is rare, and only few cases had been reported. Case Presentation. A 53-year-old woman presented with progressive shortness of breath and swelling of body for four months. Examination showed generalized oedema and a systolic murmur over the left sternal border. Transthoracic echocardiography confirmed pulmonary hypertension with tricuspid regurgitation. Investigations revealed thyrotoxicosis and very low cholesterol levels. Diagnosis of Graves’ disease was confirmed with detection of thyrotropin receptor antibodies. Pulmonary pressure was normalized six months after antithyroid therapy. Conclusion. Thyrotoxicosis is a recognized cause of reversible pulmonary hypertension and acquired hypocholesterolemia. However, most clinicians are not aware of these associations. This case illustrates the importance of assessing thyroid function in patients presenting with pulmonary hypertension.
url http://dx.doi.org/10.1155/2020/8884061
work_keys_str_mv AT narangodaliyanageajanthashyamali pulmonaryhypertensionandhypocholesterolemiasecondarytothyrotoxicosis
AT chandrikeponnamperuma pulmonaryhypertensionandhypocholesterolemiasecondarytothyrotoxicosis
_version_ 1715027990868393984